摘要
结核病由结核分枝杆菌引发,其耐药性问题近年来日益凸显,在全球范围内受到广泛关注。目前,耐药结核病的防治形势严峻,亟需采取有效策略应对。了解耐药结核病的耐药机制和治疗现状可为临床防治耐药结核病提供重要依据,现就耐药结核病的耐药机制及治疗研究进展进行综述,以期为临床提供借鉴。
Tuberculosis is caused by Mycobacterium tuberculosis,and the problem of its drug resistance has become increasingly prominent in recent years,attracting widespread attention globally.Currently,the situation of drug-resistant tuberculosis is grim,and effective strategies are urgently needed to deal with it.Understanding the drug resistance mechanism and treatment status of drug-resistant tuberculosis can provide an important basis for clinical prevention and treatment of drug-resistant tuberculosis.This paper reviews the progress of drug resistance mechanism and treatment of drug-resistant tuberculosis,in order to provide a reference for clinical intervention.
作者
钟珊珊
彭昱
毛蓉容
王芳
樊思桐
陈佳佳
ZHONG Shanshan;PENG Yu;MAO Rongrong;WANG Fang;FAN Sitong;CHEN Jiajia(Department of Infectious Diseases,Beilun Branch of The First Affiliated Hospital of Zhejiang University School of Medicine(People's Hospital of Beilun District,Ningbo City),Ningbo 315800,Zhejiang Province,China;Department of Outpatient,Beilun Branch of The First Affiliated Hospital of Zhejiang University School of Medicine(People's Hospital of Beilun District,Ningbo City),Ningbo 315800,Zhejiang Province,China;Department of Infectious Diseases,The First Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310003,China)
出处
《药学前沿》
CAS
2024年第10期341-349,共9页
China Pharmacist
基金
宁波市卫生健康科技计划项目(2023Y49)。
关键词
耐药结核病
耐药机制
治疗
研究进展
结核分枝杆菌
Drug-resistant tuberculosis
Mechanisms of drug resistance
Treatment
Research progress
Mycobacterium tuberculosis
